Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy: a Longitudinal Observational Study

NCT06210022 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06210022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06210022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy: a Longitudinal Observational Study
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
June 20, 2024
Completion date
March 1, 2027
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, focal epilepsy